Your institution may have access to this item. Find your institution then sign in to continue.
Title
Recent changes to FDA-approved labeling.
Abstract
Presents changes to drug labels approved by the U.S. Food and Drug Administration. Addition of hypersensitivity to iodine to the contraindications section of label for Amiodarone hydrochloride injection; Report of seizures and psychotic events as adverse events of Atovaquone and proguanil hydrochloride tablets; Expansion of the warning in the box of Lamivudine tablets and oral solution.